ABOUT THE EVENT
Join the Women in Finance Community for a hands-on workshop at the Seattle Glassblowing Studio. Guided by expert instructors, you’ll create unique pieces while enjoying light bites and festive drinks with fellow women in finance. This interactive class includes personalized instruction, ensuring you leave with a beautiful memento.
Important: Please wear closed-toe shoes and natural fiber clothing for safety.
ABOUT THE EVENT
SPONSORS
We created the Women in Finance platform to bring women in executive finance roles, across industries, together. Our aim is to create a network of the most powerful women in finance, working to elevate each other with discussion, skill-building, and connection. Through our events, our members learn more about leadership and how to excel in their roles as leaders.
SPEAKERS
Julie Eastland
Board Member / Audit Committee Chair
Dynavax Technologies
Julie Eastland has worked in the pharmaceutical industry for over three decades. Recently she served as the Chief Executive Officer of Harpoon Therapeutics, a publicly traded company, where she was a member of its board and led the turnaround and strategic sale to Merck Sharpe & Dohme in March of 2024. Prior to Harpoon, she served as Chief Operating Officer and Chief Financial Officer of ReCode Therapeutics, a private-held genetics medicine company focused on delivery of novel, anti-viral lipid nanoparticles therapeutics for respiratory diseases. Prior to ReCode, Ms. Eastland served as Chief Financial Officer and Chief Business Officer of Rainier Therapeutics, a private biopharmaceutical company focused on FGFR3 bladder cancer. Prior to Rainier, she served as Chief Financial Officer and Chief Business Officer of Cascadian Therapeutics, a publicly held oncology company developing tucatinib, a HER2 molecule now marketed as Tukysa, through the sale of the company to Seattle Genetics.
Prior to Cascadian, Ms. Eastland served as Chief Financial Officer and Vice President of Finance and Operations of VLST Corporation, a privately-held biotechnology company, and held various financial and strategic management positions at publicly traded biotechnology companies including Dendreon and Amgen. Ms. Eastland also serves as an independent Director and Chairperson of the Audit Committee on Dynavax as well as previously on Graybug Vision. Ms. Eastland received an M.B.A. from Edinburgh University Management School and a B.S. in finance from Colorado State University.
Powered by
Featured Philanthropy
YOUR HOSTS
SPEAKERS
First Name (link to linkedin profile)
Title
Company
Bio Paragraph place holder - do not exceed 65 words Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie
SPEAKERS
Bio Paragraph place holder - do not exceed 65 words Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie
First Name (link to linkedin profile)
Title
Company
YOUR HOSTS
Lauren Palley
Regional Community Chair,
Southern California
Woodruff Sawyer Vice President
ramiller@woodruffsawyer.com
YOUR HOSTS
YOUR HOSTS
Kristin Beaulieu
Regional Community Chair,
Washington
Woodruff Sawyer Vice President
kbeaulieu@woodruffsawyer.com
Lauren Palley, Esq.
Regional Community Chair
Southern California
Woodruff Sawyer Vice President
lpalley@woodruffsawyer.com
Jeanna Madlener
Regional Community Chair,
Oregon
Woodruff Sawyer Vice President,
Account Executive
jmadlener@woodruffsawyer.com
